Drug
Tridecanoic Acid
Tridecanoic Acid: highest development phase Phase 2, developed by Ultragenyx Pharmaceutical. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Ultragenyx Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tridecanoic Acid NCT03059160 | Phase 2 | Rett Syndrome |
Latest
No recent events.
Follow Tridecanoic Acid on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.